Beyond the Cornea
Our first program focuses on regenerating the ocular surface in patients with limbal stem cell deficiency. But the potential of regenerative cell therapy in ophthalmology extends further.
Corcellys aims to build on its expertise in stem cell biology, manufacturing and ocular delivery to explore future regenerative therapies for other severe eye diseases.
Our first focus is the cornea. Our longer-term vision is broader: restoring vision through regenerative cell therapies.
